Current controversies in the adjuvant therapy of colon cancer-Reference-Cited by-同舟云学术

Current controversies in the adjuvant therapy of colon cancer

Published:2004-10 Issue: Volume:15 Page:iv39-iv41
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Sobrero A.,Guglielmi A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/suppl_4/iv39/450598/mdh903.pdf

Reference20 articles.

1. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil;Laurie;The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol,1989

2. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma;Moertel;N Engl J Med,1990

3. Adjuvant therapy for patients with colon and rectal cancer;JAMA,1990

4. The benefit of leucovorinmodulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-03;Wolmark;J Clin Oncol,1993

5. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer;Lancet,1995

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of Epidermal Growth Factor Receptor in Colorectal Carcinoma;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2018

2. Gastric and colon neoplasms;A Comprehensive Guide to Geriatric Rehabilitation;2014

3. Introduction to Regulated Clinical Trials;Clinical Trials;2012

4. Surgery Combined with Oncological Treatments in Liver Metastases from Colorectal Cancer;Scandinavian Journal of Surgery;2011-03

5. Pharmacogenetics in Colorectal Cancer;Pharmacogenetics: Making cancer treatment safer and more effective;2010